Capricor Therapeutics, Inc. (NASDAQ:CAPR) has 129 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 3,818,600 | 2,032,990 | 113.85% | $116,085,440.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,421,815 | 570,837 | 20.02% | $104,023,174.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 3,399,900 | 1,699,900 | 99.99% | $103,356,960.00 |
| State Street Corp | 31 Mar, 2026 | 2,181,901 | 1,352,380 | 163.03% | $66,329,790.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,027,732 | 2,027,732 | 0.00% | $61,643,053.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 1,507,844 | 0 | 0.00% | $45,838,458.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,118,326 | 100,994 | 9.93% | $34,002,865.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 911,976 | 16,010 | 1.79% | $27,724,070.00 |
| Jones Hill Capital LP | 31 Mar, 2026 | 909,207 | 909,207 | 0.00% | $27,639,893.00 |
| Point72 Asset Management, L.P. | 31 Mar, 2026 | 821,179 | -1,018,697 | -55.37% | $24,963,842.00 |
| FMR LLC | 31 Mar, 2026 | 772,649 | -149,985 | -16.26% | $23,488,518.00 |
| Boxer Capital Management, LLC | 31 Mar, 2026 | 590,000 | 265,000 | 81.54% | $17,936,000.00 |
| JANE STREET GROUP, LLC | 31 Mar, 2026 | 566,081 | 566,081 | 0.00% | $17,208,863.00 |
| J. Goldman & Co LP | 31 Mar, 2026 | 541,522 | -53,854 | -9.05% | $16,462,269.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 539,232 | -362,764 | -40.22% | $16,392,652.00 |
| Ikarian Capital, LLC | 31 Mar, 2026 | 528,015 | -50,000 | -8.65% | $16,051,656.00 |
| Morgan Stanley | 31 Mar, 2026 | 423,819 | -162,021 | -27.66% | $12,884,097.00 |
| Northern Trust Corp | 31 Mar, 2026 | 417,543 | 66,902 | 19.08% | $12,693,308.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 415,483 | 361,664 | 672.00% | $12,630,683.00 |
| MERCER GLOBAL ADVISORS INC /ADV | 31 Mar, 2026 | 402,999 | 402,999 | 0.00% | $12,251,170.00 |